Skip to main content

Table 2 Neuroimaging

From: 18F-florbetaben Aβ imaging in mild cognitive impairment

    

MCI subtype

  
 

HC ( n = 15)

AD ( n = 15)

All MCI ( n = 45)

naMCI ( n = 4)

asMCI ( n = 12)

amMCI ( n = 29)

Neocortical SUVR

1.26 ± 0.22

1.96 ± 0.27

1.54 ± 0.27AB

1.50 ± 0.35B

1.66 ± 0.20AB

1.49 ± 0.28B

High β-amyloid, n (%)

3 (20)

15 (100)

24 (53)B

1 (25)B

10 (83)AC

13 (45)B

Hippocampal volume (cm3)

  

7.1 ± 0.9

7.1 ± 0.8

7.0 ± 0.8

7.2 ± 1.0

WMH volume (cm3)

  

10.2 ± 11.0

13.3 ± 15.5

4.8 ± 6.6C

12.0 ± 11.4

  1. AD, Alzheimer's disease; amMCI, amnestic multidomain mild cognitive impairment; asMCI, amnestic single-domain mild cognitive impairment; HC, healthy older controls; MCI, mild cognitive impairment; naMCI, nonamnestic mild cognitive impairment; SUVR, standard uptake value ratio; WMH, white matter hyperintensities. AP < 0.05, MCI subtype compared with HC. BP < 0.05, MCI subtype compared with AD. CP < 0.05, asMCI compared with amMCI.
Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193